Direct comparison with 454 pyrosequencing validates V3-loop based genotyping in patients eligible for Maraviroc initiation.

49th ICAAC, San Francisco, CA, September 12-15, 2009
L. Vandekerckhove1 , C. Verhofstede1, I. Vandenbroucke2, K. Van Baelen2, C. Booth3, H. Van Marck2, AM. Geretti3, L. Stuyver2 on behalf of the Tropism Study Group
More information